We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01829711
Recruitment Status : Active, not recruiting
First Posted : April 11, 2013
Last Update Posted : February 12, 2018
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : May 24, 2017
  Estimated Study Completion Date : May 30, 2018